- The world's first recombinant protein drug for the treatment of emphysema has been approved by the US FDA for clinical research January 13, 2022, Wuhan Healthgen Biotechnology Corp. (hereinafter referred to as “Healthgen Biotech”) received the approval of the US Food and Drug Administration (For short "FDA") for the clinical trial of Alpha 1-antitrypsin (AAT) for injection (Project No. HY1003) independen... Posted by Site editor|2022-01-13 LearnMore
- Application of OsrHSA in in vitro diagnostic (IVD) In Vitro Diagnosis (IVD) refers to extract blood, body fluids, tissues and other samples from the human body, and use in vitro testing reagents and instruments to test and calibrate the samples, which are divided into three major categories according to the methodology: biochemic... Posted by Site editor|2021-11-16 LearnMore
- Natural plant-derived beauty preservative - Lysozyme Lysozyme (LYZ), also known as cytosolic muramidase or N-acetylmuramide glycohydrolase, is an alkaline enzyme that hydrolyzes mucopolysaccharides in pathogenic bacteria. It mainly breaks the β-1,4 glycosidic bond between N-acetylmuramide and N-acetylamino glucose in the bacte... Posted by Site editor|2021-11-16 LearnMore
- Healthgen Biotech Sincerely Invites Agents Healthgen Biotech invites you to join us and expand the business of Healthgen Biotech biological reagents and excipient markets. Agents benefit guarantee cGMP standard ISO certified high and stable quality products. Rice endosperm protein ex... Posted by Site editor|2021-11-02 LearnMore
- Win-win with the times: Looking forward to the coming era of plant-derived Recombinant Human Serum Albumin Ascites is one of the common and serious complications in patients with decompensated cirrhosis and an important sign of the natural course of live cirrhosis. Once ascites occurs, the patient’s 1-year mortality rate is about 15%, and the 5-year mortality rate is 44%-85%. Th... Posted by Site editor|2021-10-22 LearnMore
Copyright ® Wuhan Healthgen Biotechnology Corp. All rights reserved. Terms and Conditions of Use
鄂ICP备12013293号-3
